Announcements Trials

Browse Landscape

Phase

Status

Recruiting 2 Completed 2 Withdrawn 1 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 4 Stomach Neoplasms 2 Esophageal Neoplasms 2 Squamous-Cell Lung Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Liver Neoplasms 1 Gallbladder Neoplasms 1 Fallopian Tube Neoplasms 1 Colonic Neoplasms 1 Biliary Tract Neoplasms 1 Adenocarcinoma of Lung 1

Interventions

Cisplatin 38 Carboplatin 28 Gemcitabine 23 Docetaxel 20 Radiotherapy 18 Etoposide 15 Paclitaxel 13 Erlotinib Hydrochloride 13 Vinorelbine 11 Drug Therapy 11 pembrolizumab 9 aumolertinib 9 apatinib 9 Pemetrexed 9 Gefitinib 9 osimertinib 7 endostar protein 7 Thoracic Surgery, Video-Assisted 7 Blood Specimen Collection 7 camrelizumab 6 anlotinib 6 Vinblastine 6 Surgical Procedures, Operative 6 sintilimab 5 Radiosurgery 5 Fluorodeoxyglucose F18 5 Cyclophosphamide 5 Bevacizumab 5 durvalumab 4 Mitomycin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Lung Neoplasms × Platinum Compounds × Clear all

NCT06000358 2023-08-21

LUCACRIMUNO

Lithuanian University of Health Sciences

Phase NA Unknown

Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡